Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients.

Christopher Puli'uveaTracey ImmanuelTaryn N GreenPeter TsaiPeter R ShepherdMaggie L Kalev-Zylinska

Published in: Hematology (Amsterdam, Netherlands) (2024)

-I724T variant does not drive MPN, but additional investigations are required to exclude any potential modulatory effect on the MPN phenotype.

Keyphrases